The objective of this study was to assess the efficacy of the use of an ex vivo produced oral
mucosa equivalent (EVPOME) for intraoral grafting procedures. Autogenous keratinocytes …

Purpose The primary objective of this study was to evaluate the safety of a tissue-
engineered human ex vivo–produced oral mucosa equivalent (EVPOME) in intraoral …

We fabricated ex vivo produced oral mucosa equivalent (EVPOME) from patients' oral
mucosal keratinocytes without using animal-derived serum or feeder layer cells. To confirm …

A problem maxillofacial surgeons face is a lack of sufficient autogenous oral mucosa for
reconstruction of the oral cavity. Split-thickness or oral mucosa grafts require more than one …

The aim of this study was to determine the optimal stage of development at which transplant
human ex vivo-produced oral mucosa equivalents (EVPOMEs) in vivo. EVPOMEs were …

To cite this article: Liu J, Bian Z, Kuijpers‐Jagtman AM, Von den Hoff JW: Skin and oral
mucosa equivalents: construction and performance Orthod Craniofac Res 2010; 13: 11–20 …

Purpose: The aim of this study was the ex vivo development of a composite oral mucosal
equivalent composed of a continuous stratified layer of human oral keratinocytes grown on a …

Tissue-engineered skin equivalents composed of epidermal and dermal components have
been widely investigated for coverage of full-thickness skin defects. We developed a tissue …

Purpose: This article describes the use of tissue-engineered mucosal grafts instead of split-
thickness skin grafts after freeing of the tongue in patients who had previous resection of an …

Tissue shortage complicates the surgery of cleft palate (CP) anomalies. The healing of
defects on the palate impairs growth of the dento-maxillary complex due to scar tissue …